Order results by:
Issue | Title | |
Vol 10, No 2 (2014) | RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL | Abstract similar documents |
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson | ||
"... лечением (m-ITT). Результаты. У больных ИМ с подъемом сегмента ST ривароксабан снизил в сравнении с ..." | ||
Vol 12, No 5 (2016) | The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin | Abstract similar documents |
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich | ||
"... Цель. Изучить влияние терапии ривароксабаном на частоту развития кардиоэмболических инсультов и ..." | ||
Vol 14, No 5 (2018) | Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA | Abstract similar documents |
Bayer Company Press Release | ||
"... антикоагулянта ривароксабана в дозе 2,5 мг 2 р/д в сочетании с 75-100 мг ацетилсалициловой кислоты один раз в ..." | ||
Vol 13, No 2 (2017) | RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY | Abstract similar documents |
. Editorial | ||
"... эффективность и безопасность ривароксабана в дозах 20 мг 1 р/д*, 10 мг 1 р/д и ацетилсалициловой кислоты в дозе ..." | ||
Vol 15, No 5 (2019) | Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review | Abstract similar documents |
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
"... препаратами по сравнению с варфарином, расширили возможности антикоагулянтной терапии. Прямые пероральные ..." | ||
Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
"... В некоторых отечественных публикациях высказывается мнение о том, что ривароксабан обладает ..." | ||
Vol 16, No 2 (2020) | The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality | Abstract similar documents |
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
"... в сравнении с варфарином, а риск коронарных событий не зависел от наличия у пациента ишемической ..." | ||
Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
N. M. Vorobyeva, O. N. kacheva | ||
"... безопасности ривароксабана по сравнению с варфарином в данных возрастных подгруппах. Так, у пациентов старше 80 ..." | ||
Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
"... продемонстрировало, что из трех ППОАК по сравнению с варфарином только терапия ривароксабаном снижала риск инсульта ..." | ||
Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
"... благоприятный профиль эффективности и безопасности ривароксабана в сравнении с варфарином у пациентов 75 лет и ..." | ||
Vol 13, No 1 (2017) | CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova | ||
"... Цель. Сравнить экономическую эффективность применения прямых ингибиторов Ха фактора ривароксабана ..." | ||
Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
"... Проводится непрямое статистическое сравнение представителей класса новых пероральных ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... существенно снижает частоту всех сердечно-сосудистых осложнений по сравнению с варфарином и ривароксабаном ..." | ||
Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
"... сравнении эффективности и безопасности ПОАК, основанном на рандомизированных клинических исследованиях (РКИ ..." | ||
Vol 9, No 2 (2013) | ELECTROCARDIOGRAM ST SEGMENT DEPRESSION AND ELEVATION IN STRESS-TESTING | Abstract similar documents |
D. A. Kuzhel, G. V. Matyushin, T. D. Fedorova, N. V. Kovaleva, E. A. Savchenko, S. E. Golovenkin | ||
"... . Отведения с подъемом сегмента ST указывают на пораженную коронарную артерию. ..." | ||
Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... препаратами (ацетилсалициловая кислота) и новыми пероральными антикоагулянтами (апиксабан, ривароксабан и ..." | ||
Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
I. S. Yavelov | ||
"... . The results of a large randomized placebo-controlled PEGASUS-TIMI 54 trial on the evaluation of efficacy ..." | ||
Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
S. G. Kanorskii | ||
"... ФП следует ожидать относительно низкие уровни приверженности к лекарственным средствам по сравнению с ..." | ||
Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
T. V. Pavlova | ||
"... антикоагулянт прямого действия ривароксабан по результатам РКИ ROCKET AF в подгруппе больных в возрасте 75 лет и ..." | ||
Vol 15, No 1 (2019) | Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction | Abstract PDF (Eng) similar documents |
Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy | ||
"... continuous I/V infusion. Features related to of myocardial salvage in the form of TIMI flow grade 3 ..." | ||
Vol 10, No 3 (2014) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
"... , имеющим самый большой перечень показаний к применению и очень привлекательным, является ривароксабан. ..." | ||
Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
"... рекомендаций по диагностике психических расстройств, к КН относится снижение по сравнению с преморбидным ..." | ||
Vol 8, No 3 (2012) | RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
M. Yu. Gilyarov | ||
"... средства, в частности, ривароксабан. Эффективность и безопасность ривароксабана рассматривается на основе ..." | ||
Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
M. Yu. Gilyarov | ||
"... безопасности отдельно рассматривается ривароксабан. ..." | ||
Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
S. G. Kanorskii | ||
"... В исследовании XANTUS оценены безопасность и эффективность ингибитора фактора Xa ривароксабана в ..." | ||
Vol 5, No 5 (2009) | MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION | Abstract similar documents |
Frans Van de Werf, Jeroen Bax, Amadeo Betriu, Carina Blomstrom-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, Annika Rosengren, P. Gabriel Steg, Marco Tubaro, Freek Verheugt, Franz Weidinger, Michael Weis, M. O. Evseev | ||
Vol 5, No 6 (2009) | MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION (ENDING) | Abstract similar documents |
Frans Van de Werf, Jeroen Bax, Amadeo Betriu, Carina Blomstrom-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, Annika Rosengren, P. Gabriel Steg, Marco Tubaro, Freek Verheugt, Franz Weidinger, Michael Weis, M. O. Evseev | ||
Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
A. V. Rudakova, V. A. Parfenov | ||
"... , ривароксабан и дабигатран. Использование варфарина осложняется необходимостью индивидуального подбора дозы и ..." | ||
Vol 14, No 6 (2018) | The Results of Rivaroxaban Studies COMMANDER HF and MARINER Were Published. Bayer Company Press Release . | Abstract PDF (Eng) similar documents |
artilce Editorial | ||
Vol 12, No 1 (2016) | Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita | Abstract similar documents |
S. N. Bel'diev | ||
"... В настоящее время отсутствуют общепринятые рекомендации по применению ривароксабана совместно с ..." | ||
Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
S. R. Gilyarevskiy | ||
"... монотерапии ривароксабаном. ..." | ||
Vol 13, No 1 (2017) | DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT | Abstract similar documents |
D. А. Napalkov, A. A. Sokolova, V. V. Fomin | ||
"... ARISTOTLE. Ривароксабан, напротив, продемонстрировал наихудший профиль безопасности, чаще всего вызывая ..." | ||
Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
"... кровотечения при приеме ривароксабана у пациента-носителя аллельных вариантов по полиморфизмам rs2032582 и rs ..." | ||
Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract similar documents |
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract similar documents |
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
"... нового поколения, включающих дабигатран, ривароксабан и апиксабан, с позиции безопасности терапии ..." | ||
Vol 12, No 2 (2016) | THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE | Abstract similar documents |
S. V. Moiseev | ||
"... Новые пероральные антикоагулянты, ингибирующие фактор Xa (ривароксабан, апиксабан, эдоксабан) или ..." | ||
Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
Yu. A. Bunin, S. V. Miklishanskaya | ||
Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
Vol 16, No 3 (2020) | Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics? | Abstract similar documents |
S. G. Kanorskii | ||
"... атеросклеротических сердечно-сосудистых заболеваний. При использовании низких доз ривароксабана и аспирина в группах ..." | ||
Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
"... прогрессирование ухудшения фильтрационной функции почек. Этим требованиям может соответствовать ривароксабан, при ..." | ||
Vol 16, No 5 (2020) | New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev | ||
"... применения ривароксабана и дабигатрана у пациентов различных нозологических групп: фибрилляция предсердий ..." | ||
Vol 16, No 4 (2020) | Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? | Abstract similar documents |
O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova | ||
"... атеросклероза периферических артерий с помощью комбинации антикоагулянта – ривароксабана и антиагреганта ..." | ||
Vol 11, No 5 (2015) | New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation | Abstract similar documents |
article Editorial | ||
"... предсердий, подтверждают низкую частоту кровотечений при использовании ривароксабана (Ксарелто®) • Недавно ..." | ||
Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
"... клинического применения оказалась комбинация ривароксабана в дозе 2,5 мг 2 раза в день и антиагрегантной ..." | ||
Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
"... – ривароксабан и апиксабан), были включены в когортное исследование в параллельных группах. Помимо оценки ..." | ||
Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
Vol 15, No 3 (2019) | Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities | Abstract similar documents |
article Editorial | ||
"... как коагуляционного, так и тромбоцитарного звена). Эксперты отметили, что терапия ривароксабаном 2 ..." | ||
Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
"... пациенты ≥75 лет с подтвержденной ФП, получающие дабигатран в сниженной дозе, апиксабан или ривароксабан в ..." | ||
Vol 15, No 6 (2019) | New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease | Abstract similar documents |
N. B. Perepech | ||
"... с хронической ИБС или заболеванием периферических артерий комбинированной терапии ривароксабаном и ..." | ||
Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
"... ,9±4,9) мес дабигатран принимали 38,5% (n=166), ривароксабан – 41,3% (n=178), апиксабан – 20,2% (n=87 ..." | ||
Vol 16, No 2 (2020) | Off-Label Medicines Use: Complex Problem of Modern Clinical Practice | Abstract similar documents |
S. R. Gilyarevskiy | ||
Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
К. V. Lobastov, I. V. Schastlivtsev | ||
"... сравнении с АВК длительное использование НМГ позволяет уменьшить риск рецидива ВТЭО без влияния на опасность ..." | ||
Vol 13, No 4 (2017) | COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE | Abstract similar documents |
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov | ||
"... .66) as well as antegrade coronary blood flow through the infarct-related artery TIMI II-III in 61% and 67 ..." | ||
Vol 13, No 5 (2017) | RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE | Abstract similar documents |
статья Редакционная | ||
Vol 13, No 2 (2017) | ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES | Abstract similar documents |
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich | ||
Vol 12, No 5 (2016) | Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko | ||
Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... пероральных антикоа- гулянтов прямого действия по сравнению с варфарином только терапия ривароксабаном снижала ..." | ||
Vol 12, No 4 (2016) | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) | Abstract similar documents |
Article Editorial | ||
"... внутричерепных кровотечений на фоне терапии препаратом Ксарелто® (ривароксабан) по сравнению с варфарином у ..." | ||
Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
A. N. Meshkov | ||
"... эффективности терапии розувастатином в сравнении с другими статинами, полученные в контролируемых клинических ..." | ||
Vol 12, No 6 (2016) | NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY | Abstract similar documents |
article editorial | ||
Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
"... сравнении трех ПОАК между собой апиксабан отличается более низким риском геморрагических осложнений, тогда ..." | ||
Vol 6, No 2 (2010) | COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION | Abstract similar documents |
Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova | ||
"... сравнению с 3 больными в группе эналаприла (12%). В обеих группах отмечено статистически значимое улучшение ..." | ||
Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
"... (ССЗ). Результаты. В регистре ЛИС-3 по сравнению с регистром ЛИС-1 несколько чаще на догоспитальном ..." | ||
Vol 14, No 1 (2018) | OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY | Abstract similar documents |
N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich | ||
"... . Выполнено сравнение данных о терапии, получаемой до развития референсного ОКС в госпитальном регистре ЛИС-3 ..." | ||
Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
"... статистически значимое снижение показателей ФВД. Заключение. Проведенное сравнение двух препаратов бисопролола ..." | ||
Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
O. P. Bobrova, M. M. Petrova | ||
"... антигипертензивное действие оригинального эналаприла в течение суток после однократного приема по сравнению с ..." | ||
Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
"... сравнении с метопрололом (М) у пациентов с артериальной гипертонией избыточной массой тела/ожирением ..." | ||
Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
"... сравнению с группой 1 отмечено статистически значимое снижение уровней липопротеидов низкой плотности ..." | ||
Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
"... ,0 мм рт.ст. по сравнению с исходным, после 6-недельной терапии Тритаце — на 22,2 мм рт.ст. Средний ..." | ||
Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
"... (Диован, Новартис Фарма) в качестве моно- или комбинированной терапии у курящих в сравнении с некурящими ..." | ||
Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
S. N. Tolpygina, S. Y. Martsevich | ||
"... Симвагексал – в сравнении с оригинальным препаратом симвастатина Зокором у пациентов с гиперлипидемией в ..." | ||
Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE | Abstract similar documents |
I. I. Sinitsina, V. A. Orlov, G. J. Zaharova | ||
Vol 4, No 5 (2008) | CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko | ||
Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
S. Yu. Martsevich, Y. V. Lukina | ||
"... появилась целая группа новых ОАК (НОАК). В России зарегистрированы дабигатран, ривароксабан и апиксабан. Все ..." | ||
Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
"... левого желудочка по сравнению с фозиноприлом и метопрололом. Амлодипин и фозиноприл положительно влияли ..." | ||
Vol 2, No 4 (2006) | THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak | ||
"... infarction are analyzed: GISSI, ISSIS, TIMI, GUSTO, INJECT, ASSENT. The possibility to increase in efficacy ..." | ||
Vol 12, No 2 (2016) | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE | Abstract similar documents |
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov | ||
"... % in 180 min was reached in 66% of patients and angiographic effect TIMI 2-3 – in 60% of patients ..." | ||
Vol 13, No 1 (2017) | COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY | Abstract similar documents |
A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich | ||
Vol 13, No 1 (2017) | LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER | Abstract similar documents |
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels | ||
"... сравнение госпитальных регистров, проводимых в городе Люберцы: регистра острого ИМ ЛИС-1 (2005-2007 гг.) и ..." | ||
Vol 9, No 2 (2013) | COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES | Abstract similar documents |
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. I. Nasonov | ||
Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
"... проатерогенный профиль крови. В группе МТ больше пациентов принимало статины (n=19; 57,6%), по сравнению с ..." | ||
Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
"... фармакоэкономическую эффективность применения дабигатрана этексилата в сравнении с варфарином в профилактике сердечно ..." | ||
Vol 9, No 2 (2013) | ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES | Abstract similar documents |
Z. M. Safiullina, S. V. Shalaev | ||
"... дабигатрана, прямых ингибиторов Xа фактора свёртывания ривароксабана и апиксабана в лечении неклапанной формы ..." | ||
Vol 13, No 1 (2017) | RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION | Abstract similar documents |
V. B. Kostogryz | ||
"... coronary angiography (n=15), antegrade blood flow TIMI 3 was visualized in 100% of cases. Hospital ..." | ||
Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpigina | ||
"... части статьи [1]. Выявлено повышение МИЭФ в группе 1 как по сравнению с исходным уровнем, так и с ..." | ||
Vol 9, No 6 (2013) | THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | Abstract similar documents |
A. V. Shulkin, E. N. Yakusheva, N. M. Popova | ||
"... , ривароксабаном, эдоксабаном) не является целесообразным в рутинной практике. Клиническое значение для ..." | ||
Vol 16, No 4 (2020) | The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation? | Abstract similar documents |
S. Yu. Martsevich | ||
"... , проанализировав крупную базу данных больных с фибрилляцией предсердий, пришли к выводу, что ривароксабан уступает ..." | ||
Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
"... % – дабигатран, 2% – ривароксабан). На долю пациентов, получавших дабигатран, пришлось 4,2% кровотечений (от ..." | ||
Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
"... , подъем сегмента ST в III, фибрилляция предсердий. ЭКГ-признак SIQIII ассоциировался с повышением риска ..." | ||
Vol 14, No 2 (2018) | New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion | Abstract similar documents |
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko | ||
"... продемонстрировано в недавно опубликованном исследовании COMPASS. Назначение малых доз ривароксабана дополнительно к ..." | ||
Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
N. A. Novikova, A. N. Volovchenko | ||
"... ривароксабана и апиксабана при подготовке и проведении электрической кардиоверсии у больных с неклапанной ФП. Во ..." | ||
Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) similar documents |
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
"... назначен в 11 (64,7%) случаях, а ривароксабан – в 6 (35,3%). Заключение. В реальной клинической практике ..." | ||
Vol 16, No 5 (2020) | Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage | Abstract similar documents |
N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
"... тромбоэмболий. Только 24,4% терапевтов считают возможным назначить ривароксабан в дозе 2,5 мг 2 р/сут пациенту ..." | ||
Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
"... время визита В0 111 (55,2%) больным был рекомендован прием ривароксабана; 47 (23,4%) – дабигатрана и 43 ..." | ||
Vol 11, No 2 (2015) | A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE | Abstract similar documents |
B. B. Gegenava, O. M. Drapkina | ||
"... сравнении со спиронолактоном. ..." | ||
1 - 100 of 415 Items | 1 2 3 4 5 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)